Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Semaphorin 3c ELISA Kit (AC3703)
Cat.#: ASET-2292
Specifications
Description Human Semaphorin 3c ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Semaphorin 3c concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 10.23 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1056 Human EN2 ELISA Kit (AC2467) Quantitative inquiry ASET-1812 Human Dynamin 2 ELISA Kit (AC3223) Quantitative inquiry ASET-2254 Mouse Neuropeptide S ELISA Kit (AC3665) Quantitative inquiry ASET-1673 Mouse NKCC1 ELISA Kit (AC3084) Quantitative inquiry ASET-1318 Guinea Pig TIMP1 ELISA Kit (AC2729) Quantitative inquiry ASET-2051 Human Cx30 ELISA Kit (AC3462) Quantitative inquiry ASET-1754 Human TRPV2 ELISA Kit (AC3165) Quantitative inquiry ASET-2439 Human PON3 ELISA Kit (AC3850) Quantitative inquiry ASET-1237 Human NRXN3 ELISA Kit (AC2648) Quantitative inquiry ASET-1965 Human 14-3-3 zeta ELISA Kit (AC3376) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket